Vivian H Liu - Net Worth and Insider Trading

Vivian H Liu Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Vivian H Liu owns 4 companies in total, including Innovus Pharmaceuticals Inc (INNV) , ThermoGenesis Holdings Inc (THMO) , and Seelos Therapeutics Inc (SEEL) among others .

Click here to see the complete history of Vivian H Liu’s form 4 insider trades.

Insider Ownership Summary of Vivian H Liu

Ticker	Comapny	Transaction Date	Type of Owner
INNV	Innovus Pharmaceuticals Inc	2020-01-02	director
THMO	ThermoGenesis Holdings Inc	2016-11-03	director
SEEL	Seelos Therapeutics Inc	2004-12-31	Vice President & CFO
		2023-08-11	director

Vivian H Liu Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Vivian H Liu Ownership Network

Ownership Network List of Vivian H Liu

No Data

Ownership Network Relation of Vivian H Liu

Vivian H Liu Owned Company Details

What does Innovus Pharmaceuticals Inc do?

Who are the key executives at Innovus Pharmaceuticals Inc?

Vivian H Liu is the director of Innovus Pharmaceuticals Inc. Other key executives at Innovus Pharmaceuticals Inc include 10 percent owner Armistice Capital, Llc , 10 percent owner Armistice Capital Master Fund Ltd. , and 10 percent owner Steven Boyd .

Innovus Pharmaceuticals Inc (INNV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Innovus Pharmaceuticals Inc (INNV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Innovus Pharmaceuticals Inc (INNV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Innovus Pharmaceuticals Inc (INNV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Innovus Pharmaceuticals Inc Insider Transactions

No Available Data

What does ThermoGenesis Holdings Inc do?

Who are the key executives at ThermoGenesis Holdings Inc?

Vivian H Liu is the director of ThermoGenesis Holdings Inc. Other key executives at ThermoGenesis Holdings Inc include 10 percent owner Boyalife (hong Kong) Ltd , 10 percent owner Boyalife Asset Holding Ii, Inc. , and 10 percent owner Boyalife Group, Inc. .

ThermoGenesis Holdings Inc (THMO) Insider Trades Summary

Over the past 18 months, Vivian H Liu made no insider transaction in ThermoGenesis Holdings Inc (THMO). Other recent insider transactions involving ThermoGenesis Holdings Inc (THMO) include a net sale of 600,000 shares made by Xiaochun Xu ,

In summary, during the past 3 months, insiders sold 0 shares of ThermoGenesis Holdings Inc (THMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 600,000 shares of ThermoGenesis Holdings Inc (THMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 600,000 shares.

ThermoGenesis Holdings Inc (THMO)'s detailed insider trading history can be found in Insider Trading Tracker table.

ThermoGenesis Holdings Inc Insider Transactions

No Available Data

What does Seelos Therapeutics Inc do?

Who are the key executives at Seelos Therapeutics Inc?

Vivian H Liu is the Vice President & CFO of Seelos Therapeutics Inc. Other key executives at Seelos Therapeutics Inc include director & See Remarks Raj Mehra , Chief Financial Officer Michael Joseph Golembiewski , and SVP & Chief Business Officer Neil Morton .

Seelos Therapeutics Inc (SEEL) Insider Trades Summary

Over the past 18 months, Vivian H Liu made no insider transaction in Seelos Therapeutics Inc (SEEL). Other recent insider transactions involving Seelos Therapeutics Inc (SEEL) include a net purchase of 83,000 shares made by Michael Joseph Golembiewski , and a net purchase of 75,757 shares made by Raj Mehra .

In summary, during the past 3 months, insiders sold 0 shares of Seelos Therapeutics Inc (SEEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Seelos Therapeutics Inc (SEEL) were sold and 19,845 shares were bought by its insiders, resulting in a net purchase of 19,845 shares.

Seelos Therapeutics Inc (SEEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Seelos Therapeutics Inc Insider Transactions

No Available Data

What does Aytu BioPharma Inc do?

Who are the key executives at Aytu BioPharma Inc?

Vivian H Liu is the director of Aytu BioPharma Inc. Other key executives at Aytu BioPharma Inc include Chief Financial Officer Mark K Oki , Chief Operating Officer Christopher Brooke , and Chief Business Officer Jarrett Disbrow .

Aytu BioPharma Inc (AYTU) Insider Trades Summary

Over the past 18 months, Vivian H Liu made no insider transaction in Aytu BioPharma Inc (AYTU). Other recent insider transactions involving Aytu BioPharma Inc (AYTU) include a net purchase of 126,371 shares made by Joshua R. Disbrow , and a net purchase of 100,000 shares made by Greg Pyszczymuka .

In summary, during the past 3 months, insiders sold 0 shares of Aytu BioPharma Inc (AYTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aytu BioPharma Inc (AYTU) were sold and 24,619 shares were bought by its insiders, resulting in a net purchase of 24,619 shares.

Aytu BioPharma Inc (AYTU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aytu BioPharma Inc Insider Transactions

No Available Data

Vivian H Liu Mailing Address

Above is the net worth, insider trading, and ownership report for Vivian H Liu. Currently GuruFocus does not have mailing address information for Vivian H Liu.

Discussions on Vivian H Liu

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.